LncRNA LNCRI: A Potential Drug Target Or Biomarker (G401296)

LncRNA LNCRI: A Potential Drug Target Or Biomarker

LNCRI (LncRNA Radiation-Induced Regulator of PLK1 and RAD51) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker in various diseases, including cancer. Its unique mechanism of action and subcellular localization have made it an attractive target for researchers to investigate.

LncRNA is a class of non-coding RNA molecules that have been identified in various organisms, including humans. These molecules are usually involved in the regulation of gene expression and can have a wide range of functions, including controlling cell growth, cell differentiation, and cell survival.

The PLK1 (Plk1) and RAD51 are two key genes that have been well-studied in the context of LncRNA regulation. PLK1 is a protein that is involved in the regulation of cell-cell adhesion, while RAD51 is a protein that is involved in the repair of DNA damage.

Radiation-Induced Regulator of PLK1 and RAD51 (LNCRI) is a non-coding RNA molecule that has been shown to have a positive impact on the expression and activity of PLK1 and RAD51. It is composed of 215 amino acid residues and has a unique structure that consists of a cytoplasmic tail and a nuclear body.

The cytoplasmic tail of LNCRI is composed of 11 amino acids and is involved in the stability of the molecule. The nuclear body of LNCRI consists of the central region and the terminal region. The central region of LNCRI contains the key binding sites for the PLK1 and RAD51, while the terminal region contains the regions responsible for the stability and translation of the molecule.

LncRNA Radiation-Induced Regulator of PLK1 and RAD51 (LNCRI) has been shown to play a crucial role in the regulation of PLK1 and RAD51. It has been shown to enhance the expression and activity of PLK1 and RAD51, which are involved in the regulation of cell growth, cell differentiation, and cell survival.

In addition to its positive impact on PLK1 and RAD51, LNCRI has also been shown to have a negative impact on the expression and activity of other genes. For example, it has been shown to repress the expression of the genes involved in cell adhesion, migration, and invasion.

LncRNA Radiation-Induced Regulator of PLK1 and RAD51 (LNCRI) may be a drug target or biomarker due to its unique mechanism of action and subcellular localization. Its ability to enhance the expression and activity of PLK1 and RAD51, as well as its negative impact on other genes, make it an attractive target for researchers to investigate further.

In conclusion, LncRNA Radiation-Induced Regulator of PLK1 and RAD51 (LNCRI) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker due to its unique mechanism of action and subcellular localization. Further research is needed to fully understand its role in the regulation of PLK1 and RAD51, as well as its potential as a drug target or biomarker.

Protein Name: LncRNA Radiation Induced Regulator Of PLK1 And RAD51

The "LNCRI Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LNCRI comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LNCRNA-ATB | LNCRNA-IUR | LNCTAM34A | LNP1 | LNPEP | LNPK | LNX1 | LNX1-AS1 | LNX2 | LOC100127946 | LOC100127955 | LOC100128002 | LOC100128028 | LOC100128050 | LOC100128059 | LOC100128079 | LOC100128093 | LOC100128164 | LOC100128242 | LOC100128288 | LOC100128317 | LOC100128361 | LOC100128398 | LOC100128494 | LOC100128593 | LOC100128770 | LOC100128966 | LOC100128988 | LOC100129034 | LOC100129098 | LOC100129148 | LOC100129175 | LOC100129203 | LOC100129215 | LOC100129316 | LOC100129381 | LOC100129434 | LOC100129455 | LOC100129534 | LOC100129603 | LOC100129697 | LOC100130000 | LOC100130207 | LOC100130285 | LOC100130298 | LOC100130331 | LOC100130452 | LOC100130463 | LOC100130548 | LOC100130587 | LOC100130691 | LOC100130698 | LOC100130744 | LOC100130748 | LOC100130872 | LOC100130899 | LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735